Notch and Wnt signaling in protection by nandrolone against disuse atrophy
Notch 和 Wnt 信号传导在诺龙防止废用性萎缩中的保护作用
基本信息
- 批准号:8202501
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-04-01 至 2016-03-31
- 项目状态:已结题
- 来源:
- 关键词:AdultAffectAndrogen ReceptorAndrogen Response ElementAnimal ModelAsthmaAtrophicBindingBinding SitesBurn injuryCell Culture TechniquesCell NucleusCell physiologyCellsChronic Obstructive Airway DiseaseCommitCommunitiesDNADNA BindingDNA SequenceDataDenervationDiseaseDisuse AtrophyEventFiberFutureGene ExpressionGenesGenetic TranscriptionHypertrophyImmobilizationImmunohistochemistryInjuryKnock-outKnowledgeLigand BindingLigandsMediatingMedicalMesenchymal Stem CellsMessenger RNAMolecularMuscleMuscle FibersMuscular AtrophyMyoblastsNandroloneNerveNuclear TranslocationParalysedPharmaceutical PreparationsPlayProliferatingProteolysisQuality of lifeRecoveryResponse ElementsRoleSequence AnalysisSignal TransductionSiteSkeletal MuscleSoldierSpeedSpinal cord injuryStrokeTCF Transcription FactorTestingTimeTransgenic MiceUp-RegulationVeteransactivating transcription factorcell typedaughter cellfunctional restorationimprovedinhibitor/antagonistmRNA Stabilitymouse modelmuscle formnotch proteinoverexpressionpreventpromoterreceptorresearch studyrestorationsatellite cellself-renewaltissue repairtranscription factor
项目摘要
DESCRIPTION (provided by applicant):
The current proposal grew from studies of the molecular mechanisms by which nandrolone protects against muscle atrophy caused by nerve transection and were stimulated by findings that Notch and Wnt play critical roles in tissue repair after muscle injury. Notch stimulates proliferation of satellite cells, a mesenchymal 'stem' cell capable of proliferating to allow self-renewal, and of producing daughter cells able to commit to the skeletal muscle lineage, form myoblasts, and fuse to form new muscle fibers or contribute to existing ones. Wnt inhibits Notch signaling and stimulates myogenic differentiation. Our preliminary data suggest that denervation activates Notch and Wnt signaling in denervated muscle and that nandrolone terminates Notch signaling while further increasing Wnt signaling. Termination of Notch signaling by nandrolone is associated with increased expression of the Notch inhibitor Numb. A preliminary analysis of the sequence of the Numb promotor suggests that it contains binding sites for transcription factors (TCF/LEF) by which Wnts regulate gene expression through activation and nuclear translocation of the transcriptional regulator ss-catenin, as well as possible androgen receptor response elements; the androgen receptor is a ligand-activated transcription factor that binds to such sites to upregulate gene expression. Our hypothesis is that nandrolone induces upregulation of Numb and Wnt signaling in satellite cells, which is critical to protection against atrophy by nandrolone, and dependent upon upregulation of Numb transcription; upregulation is mediated by the androgen receptor and Wnt signaling. The following specific aims are proposed: 1. Determine the cell type(s) in which nandrolone alters Numb, and signaling by Notch and ss- catenin. Our hypothesis is that nandrolone regulates Numb expression and Notch and ss-catenin- dependent signaling in satellite cells and that effects of nandrolone on Numb expression and ss-catenin- dependent signaling occur in the same cells. In a mouse model of denervation atrophy, we will determine the cell type in which nandrolone upregulates Numb and signaling by ss-catenin by immunohistochemistry. 2. Examine the role of Numb in nandrolone-induced inhibition of Notch signaling and protection against denervation atrophy. Our hypothesis is that upregulation of Numb terminates Notch signaling and is necessary for effects of nandrolone to protect against denervation atrophy. We will use a transgenic mouse in which the Numb gene can be inactivated at a specific time. Experiments will test whether inactivation of the Numb gene blocks effects of nandrolone on Notch signaling and protection against muscle atrophy in a mouse model of denervation atrophy. 3. Characterize molecular mechanisms by which nandrolone upregulates Numb. Our hypothesis is that the Numb promotor contains a cluster of androgen response elements, and thus upregulation of Numb by nandrolone requires binding of the androgen receptor to these DNA sequences. In animal models, we will test the role for Wnt signaling in Numb expression in denervated muscle by either knocking out ss-catenin or overexpressing Wnts or their inhibitors. In cell culture, we will determine whether: binding of nandrolone to the androgen receptor (AR) is needed for upregulation of Numb by nandrolone; AREs within the Numb promotor function to upregulate its transcription; and nandrolone alters Numb mRNA stability.
描述(由申请人提供):
目前的提议源于对诺龙防止神经横断引起的肌肉萎缩的分子机制的研究,并受到 Notch 和 Wnt 在肌肉损伤后组织修复中发挥关键作用的发现的刺激。 Notch 刺激卫星细胞的增殖,卫星细胞是一种间充质“干”细胞,能够增殖以实现自我更新,并产生能够分化为骨骼肌谱系、形成成肌细胞并融合形成新肌纤维或有助于现有肌纤维的子细胞。那些。 Wnt 抑制 Notch 信号传导并刺激生肌分化。我们的初步数据表明,去神经激活了去神经肌肉中的Notch和Wnt信号传导,诺龙终止了Notch信号传导,同时进一步增强了Wnt信号传导。诺龙终止 Notch 信号传导与 Notch 抑制剂 Numb 的表达增加相关。对 Numb 启动子序列的初步分析表明,它包含转录因子 (TCF/LEF) 的结合位点,Wnts 通过转录因子 ss-catenin 的激活和核易位以及可能的雄激素受体反应来调节基因表达元素;雄激素受体是一种配体激活的转录因子,它与这些位点结合以上调基因表达。我们的假设是,诺龙诱导卫星细胞中 Numb 和 Wnt 信号的上调,这对于诺龙防止萎缩至关重要,并且依赖于 Numb 转录的上调;上调由雄激素受体和 Wnt 信号传导介导。提出以下具体目标: 1. 确定诺龙改变 Numb 的细胞类型以及 Notch 和 ss-catenin 的信号传导。我们的假设是诺龙调节卫星细胞中的 Numb 表达以及 Notch 和 ss-catenin 依赖性信号传导,并且诺龙对 Numb 表达和 ss-catenin 依赖性信号传导的影响发生在相同的细胞中。在去神经萎缩的小鼠模型中,我们将通过免疫组织化学确定诺龙上调 Numb 和 ss-catenin 信号传导的细胞类型。 2. 检查 Numb 在诺龙诱导的 Notch 信号传导抑制和防止去神经萎缩中的作用。我们的假设是,Numb 的上调会终止 Notch 信号传导,并且对于诺龙防止去神经萎缩的作用是必要的。我们将使用一种转基因小鼠,其中 Numb 基因可以在特定时间失活。实验将测试 Numb 基因失活是否会阻止诺龙对去神经萎缩小鼠模型中 Notch 信号传导和防止肌肉萎缩的影响。 3. 表征诺龙上调 Numb 的分子机制。我们的假设是 Numb 启动子含有一组雄激素反应元件,因此诺龙对 Numb 的上调需要雄激素受体与这些 DNA 序列结合。在动物模型中,我们将通过敲除 ss-catenin 或过表达 Wnt 或其抑制剂来测试 Wnt 信号传导在去神经肌肉 Numb 表达中的作用。在细胞培养中,我们将确定: 诺龙与雄激素受体 (AR) 的结合是否是诺龙上调 Numb 所必需的; Numb 启动子内的 ARE 具有上调其转录的功能;诺龙会改变 Numb mRNA 的稳定性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHRISTOPHER P CARDOZO其他文献
CHRISTOPHER P CARDOZO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHRISTOPHER P CARDOZO', 18)}}的其他基金
Romosozumab to Improve Bone Mineral Density and Architecture in Chronic SCI
Romosozumab 可改善慢性 SCI 患者的骨矿物质密度和结构
- 批准号:
10418624 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Romosozumab to Improve Bone Mineral Density and Architecture in Chronic SCI
Romosozumab 可改善慢性 SCI 患者的骨矿物质密度和结构
- 批准号:
10664874 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Romosozumab to Improve Bone Mineral Density and Architecture in Chronic SCI
Romosozumab 可改善慢性 SCI 患者的骨矿物质密度和结构
- 批准号:
10664874 - 财政年份:2020
- 资助金额:
-- - 项目类别:
ShEEP Request for A Metabolic and Behavioral Phenotyping System
ShEEP 请求建立代谢和行为表型系统
- 批准号:
9795306 - 财政年份:2019
- 资助金额:
-- - 项目类别:
[ShEEP/LAMb] Request for a Seahorse Extracellular Flux Analyzer
[ShEEP/LAMb] 索取 Seahorse 细胞外通量分析仪
- 批准号:
9209599 - 财政年份:2016
- 资助金额:
-- - 项目类别:
Notch and Wnt signaling in protection by nandrolone against disuse atrophy
Notch 和 Wnt 信号传导在诺龙防止废用性萎缩中的保护作用
- 批准号:
8840070 - 财政年份:2012
- 资助金额:
-- - 项目类别:
Notch and Wnt signaling in protection by nandrolone against disuse atrophy
Notch 和 Wnt 信号传导在诺龙防止废用性萎缩中的保护作用
- 批准号:
8424827 - 财政年份:2012
- 资助金额:
-- - 项目类别:
Attenuation of denervation atrophy by nandrolone: molecular mechanisms
诺龙减轻去神经萎缩:分子机制
- 批准号:
7750432 - 财政年份:2009
- 资助金额:
-- - 项目类别:
相似国自然基金
PARP1介导DNA损伤修复调控雄激素受体影响前列腺癌放疗敏感性的机制研究
- 批准号:82303674
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
雄激素受体调控cIAP/RIPK2/NOD2通路影响结石免疫微环境促进肾结石发生发展的机制研究
- 批准号:82370764
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
BaP通过激活AhR调控FGF-21和雄激素受体影响非酒精性脂肪肝病的机制研究
- 批准号:82260733
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
胶质瘤干细胞外泌体衍生的circHOMER1靶向雄激素受体影响肿瘤胆固醇代谢的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
雄激素受体/线粒体β氧化轴异常对PCOS子宫内膜细胞代谢和体内稳态的影响及中药的机制研究
- 批准号:
- 批准年份:2021
- 资助金额:55 万元
- 项目类别:面上项目
相似海外基金
Generation and characterization of a Cre-Lox regulated transgenic zebrafish model of SBMA
Cre-Lox 调节的 SBMA 转基因斑马鱼模型的生成和表征
- 批准号:
10784254 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Regulation of prostate organogenesis by tissue-resident macrophages
组织驻留巨噬细胞对前列腺器官发生的调节
- 批准号:
10555589 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Nonalcoholic Fatty Liver Disease (NAFLD) in Polycystic Ovary Syndrome: The Role of Androgens on Liver Injury and NAFLD Progression
多囊卵巢综合征中的非酒精性脂肪肝 (NAFLD):雄激素在肝损伤和 NAFLD 进展中的作用
- 批准号:
10735807 - 财政年份:2023
- 资助金额:
-- - 项目类别:
The role of estrogen receptor alpha in prostatic fibrosis contributing to benign prostatic hyperplasia
雌激素受体α在导致良性前列腺增生的前列腺纤维化中的作用
- 批准号:
10607151 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Mechanisms and blood-based biomarkers of intergenerational neurobehavioral effects of general anesthetics
全身麻醉药代际神经行为效应的机制和血液生物标志物
- 批准号:
10538703 - 财政年份:2022
- 资助金额:
-- - 项目类别: